Response from the authors
Dear Sir, Dr. Odawara and colleagues report the selection of a new set of primers to detect the 3243 bp A to G mutation in the mitochondrial genome associated with maternally inherited diabetes and deafness. They suggest that the use of primers giving rise to two cleaved fragments of almost the same size will increase the sensitivity of the test. We agree that these primers could increase the intensity of the band corresponding to the mutation, but we think that the important point to improve this technique is the coloration step, the silver nitrate detection method being more sensitive than an ethidium bromide staining.
However, to decrease the cost of this test and the problems associated with heteroduplexes, we have established an allele specific method using 5 primers. Allele-specific polymerase chain reaction (PCR) is obtained using primers 5' CCG GAG TAA TCC AGG TCG G3' (3077-3095) and 5'TTT ATG CGA TTA CCG GGC T/C (3261-3243) giving rise to a 185 bp product specific of wild type or mutant allele. In each reaction, an internal positive control primer pair is included: 5' AAT TGA CCT GCC CGT GAA GA3' (2677-2696) und 5' CCC AAC CGA AAT TFT TAA TGC A3' (2816-2795) giving rise to a 140 bp product. The PCR reaction mixture consists of 100 ng genomic DNA, i x PCR buffer, 200 mmol/1 of each dNTP, 50 ng of each primer and 1 unit Taq polymerase (Perkin Elmer, Branchburg, USA). Cycling conditions were: a first denaturation at 94 ~ for 5 min, then 30 cycles of 10 s at 94~ 60~ and 72~ and a final extension at 72~ for 6 min. PCR reaction was checked on a 2 % agarose gel.
We checked the patients previously tested by the PCR-RFLP method and the same positive and negative results were obtained by both methods. Allele-specific PCR is less expensive and less time consuming than PCR-RFLP, both advantages being very important for the diagnosis of patients affected with maternally-inherited diabetes associated with deafness.
Yours sincerely, H. Blanch6, N. Cohen, R Froguel
Genetic analysis of HLA DRB1, DQA1 and DQB1 alleles and susceptibility to IDDM in Chilean subjects
Dear Sir, The incidence of insulin-dependent diabetes mellitus (IDDM) in Santiago de Chile has been reported to be 2.49 per 100,000 per year [1] , which is much lower than that reported for Madrid (11.3 per 100,000 per year) [2] or Barcelona (11.5 per 100,000 per year) [3] . These differences may be due to genetic variation between the populations (i. e. frequencies of IDDM susceptibility alleles, DQAl*Arg-52 and DQB1*non-Asp-57) in Spain and Chile [4] [5] [6] [7] , partly sharing a Spanish ancestry. Due to the lack of previous HLA studies in IDDM and in non-diabetic subjects in the general population of Chile, we have recently completed a molecular analysis [6] of DRB1, DQA1 and DQB1 alleles for 63 unrelated IDDM patients (26 male, 37 female; mean age, 12.6 years, diabetes duration 7.99 + 3.95 years), randomly chosen from the Santiago de Chile IDDM Registry for 1991-1992 [1] and 74 healthy non-diabetic control subjects (29 males, 45 females; mean age, 13.6 years) from the same geographical area according to a standardized protocol [7] . IDDM and control children were ethnically similar, belonging to the strata III of Valenzuela [8] , which represents a 40 % aborigine admixture with European genetic pools, primarily of Spanish origin.
IDDM patients showed a significant decrease in the frequency of HLA-DR2 and DR14 and an increase in DR3 and DR4 compared to non-diabetic control subjects (Table 1) . DR14, one of the strong protective alleles, was common among non-diabetic patients (6.8%). DQA1*0101-102-103 and DQAI*0201 were significantly decreased, and
Corresponding author: Dr. M. Serrano-Rios, Cea Bermudez, 66, 5G, E-28003 Madrid, Spain DQAI*0301 allele was significantly increased among cases compared to control subjects. On the other hand, only allele DQBI*0302 was significantly increased among the cases compared to control subjects. The commonest high-risk genotype found in diabetic patients was DQB1*0302/*0201-DQA1*0301/*0501 (43 %), associated with DR4/DR3 alleles in 22 % of the cases.
Also, DQA1*Arg-52 homozygotes had 18 times more risk developing IDDM than DQA1*non-Arg-52 homozygotes. Heterozygosity for DQA1*Arg52 conferred only a threefold increased risk. DQB1*non-Asp-57 homozygotes had more than a fivefold increase in IDDM risk as compared to DQBl*Asp57 homozygotes.
The highest relative and absolute IDDM risks were associated with homozygosity for both DQAl*Arg-52 and DQB1*non-Asp-57 alleles, reflecting the potential formation of diabetogenic DQa/DQ~ heterodimers, as predicted by the model of Khalil et al. [9] . Only 19 % of the general population in Chile were capable of generating four diabetogenic heterodimers, with an absolute risk for developing IDDM of 7.6 per 100,000 per year. A fivefold increase in risk was observed for those who could form two diabetogenic heterodimers while individuals (about 50 % of non-diabetic patients) able to generate one or zero diabetogenic heterodimers showed a very low risk of developing IDDM. Despite the dramatic variation in IDDM incidence in Chile as compared to Spain, the overall frequencies of DQB1 and DQA1 alleles were similar among diabetic patients and control subjects in both countries [6] . DQBI*0602 and DQBI*0301, considered to be protective for IDDM, occurred less frequently in the non-diabetic Chilean children than among those from Madrid (9.5 vs 1.9 % and 20.9 % vs 1.6 %, respectively), but these differences were not statistically significant. DQAI*0301, the most common DQA1 allele in the IDDM Chileans also had, in the Chilean general population, a frequency higher than that reported in non-diabetic Spaniards (27.7 vs 1.7 %, respectively) [6] , but not compared to other Caucasian populations. In conclusion: the low incidence of IDDM among Chileans may be attributed, at least partially, to the reduced frequency of DR3, DQB1*0201 and/or by the presence of a strongly protective allele (i. e., DR14) in Chileans, which is absent in Caucasian populations. However, the contribution of other non-HLA genes and/or environmental influences cannot be excluded as further contributors to explain the observed differences in the incidence of IDDM between Chile and Spain.
